trial · primary record
Placebo for AZD8965
Idiopathic Pulmonary Fibrosis (IPF)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 359 |
| Primary completion | 2028-09-18 |
| Primary endpoint | To evaluate the clinical efficacy of AZD8965 compared with placebo on the absolute change from baseline in FVC in mL at Week 24 |
| Registry ID | NCT07652658 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:26.365Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07652658
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.